Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I feel like Paul's done with CBTC and fully focused on PCLI now.
Thanks for the links and sharing your insight. I'm not on Instagram and hadn't seen those photos and videos. I've been meaning to contact Nikki, but haven't had a chance yet. Nice to hear the progress. Might be time to get back in here!
What do you like about PCLI? I think there's more potential here than Paul's other company CBTC. I've been following both for a few years.
At least PCLI has some houses listed for sale now in Rivers Edge. Just not sure if they'll actually be built and profitable, like none of his bitcoin mining ever was
CEO Paul got all the filings caught up this week. Look for attorney letter next, then back to pink current
https://www.otcmarkets.com/stock/CBTC/disclosure
Just posted 2022 and Q1-Q3 2023 reports. $225k net income for Q3 and started construction on 4 units
https://www.otcmarkets.com/stock/PCLI/disclosure
Wonder if Nupelo is staining or non-staining formula?
ViaDerma, Inc. Enters the (MMJ) or Medical Marijuana industry with a Patent Pending CBD Delivery System as California Votes for Expanded Uses of Cannabis
The Treatment Success of ViaDerma's Proprietary Delivery System for Several Diseases by the Efficient and Effective Transdermal Delivery of CBD's & THC to the Localized Treatment Area & into the Blood Stream
LOS ANGELES, CA--(Marketwired - November 14, 2016) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, announced today the Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases. The transdermal system can deliver through topical skin absorption to localized areas and directly into the blood stream. The Patent application using the combination of CBD's and THC with the delivery system was filed in 2014. The Patent Pending transdermal system can deliver medications and nutrients into the body through the skin. For example, a person with a migraine headache can place the CBD and THC combined with the delivery compound and apply to the neck with immediate absorption into the bloodstream through the corroded artery. ViaDerma, Inc. is also in the clinical testing stages of an anti-aging topical solution, topical pain medication, a topical for male-pattern baldness, and a topical designed to boost male libido.
On November 8th, medical and recreational marijuana was passed in several states that voted on medical marijuana provisions, in what is turning out to be, the biggest electoral victory for marijuana reform since 2012. The use of CBD's is known for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis.
ViaDerma also has Viabecline, a topical liquid tetracycline-based antibiotic that uses a patent-pending innovative transdermal delivery system that can convert oral medication active ingredients into topical drugs. The drug is FDA-registered as a first aid antibiotic to help prevent skin infection in minor cuts, scrapes, and burns, but importantly, has also shown to be effective in fighting more harmful forms of staphylococcus aureus infections, which are commonly known as 'staph infections.' Without the introduction of novel antibiotic treatments, infections can spread and sometimes become life threatening.
Market for the following Drugs:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $2.8 million in 2009, estimates of $3.02 billion by 2016
Psoriasis- $2.4 billion in 2010, estimates of over $7.3 billion by 2015
Eczema- $2.5 billion in 2014
ViaDerma sees the use of CBD's along with our Proprietary transdermal delivery system for the treatment and continuing studies look very promising and demonstrate efficacy in terms of treating several unrelated diseases. "We are enthusiastic about the results we have achieved to date in terms of the anecdotal feedback we have received from the medical community," said Dr. Christopher Otiko, ViaDerma's founder and CEO.
Contact information:
Dr. Christopher Otiko
Chief Executive Officer
Email: info@viadermalicensing.com
Phone: 310-496-5744
https://www.otcmarkets.com/stock/VDRM/news/ViaDerma-Inc-Enters-the-MMJ-or-Medical-Marijuana-industry-with-a-Patent-Pending-CBD-Delivery-System-as-California-Votes-?id=144841
Any catalysts for the recent volume? Uplist after the new year maybe?
There was a yield sign up the other night, it's back to Pink Current now.
I don't doubt that Paul is truthful, just not much has happened the past couple of years. I think all of his attention has shifted to PCLI
Q3 report is out, yield sign up
https://www.otcmarkets.com/otcapi/company/financial-report/352055/content
5 lots from the new development listed for sale https://apps.realtor.com/mUAZ/zxvqpai3
Dude said he bugged them with countless emails for a couple of months and they agreed to sell him a bottle early because his daughter needs it for a skin problem and didn't like the staining
http://stocktwits.com/TomServoToo/message/488104960
His picture was the new Ultra product
Guy on StockTwits got a bottle of Ultra, pic at link below
http://stocktwits.com/TomServoToo/message/488125829
Based on the last Q report, not much going on at all. Zero revenue, still renting storage space from CEO's other companies
https://www.otcmarkets.com/otcapi/company/financial-report/343377/content
That group of affiliated wound care practices, which Otiko is the President of, has added 3 states this year and is in 19 states now
https://npiregistry.cms.hhs.gov/registry/search-results-table?organization_name=WOUND+PROS&addressType=ANY
Progress update from twitter
$PCLI @OfficialPCLI
— Protocall Technologies ($PCLI) (@OfficialPCLI) April 13, 2022
Installation of Sewer and water mainlines in Rivers Edge 2 subdivision nearing completion. PCLI's 35 lots will generate approx. $14,000,000 of revenue from home sales.
Or schedule an appointment with Otiko's The Wound Pros company to get the Tetracyte version, assuming they're licensed in your state
https://www.thewoundpros.com/services/tetracyte
You can still get the BWell licensed version here
https://brewerwellnessshop.com/products/antibiotic-ointment-spray
Late filing notice for annual report. It says audit is not complete, expected in 2 weeks
https://www.otcmarkets.com/otcapi/company/financial-report/325985/content
This is the number in their email signature:
ViaDerma Investor Relations
310-734-6111
VitaStem works amazingly on shingles. It heals the blisters quickly and provides rapid relief for the terrible nerve pain associated with the disease. This picture was sent to us by a happy consumer who was stunned at how quickly VitaStem gave him relief. pic.twitter.com/HxyPtnQIon
— ViaDerma (@viaderma) February 18, 2022
Q3 report shows Dr owns 56,230,708 shares common stock and 30,000,000 preferred
Otiko's Wound Pros company is listed as Manager on The Wound Docs llc registration. They have a new website and apple/android apps. Hopefully this will mean more sales for VDRM
https://www.thewounddocs.com
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=CurrentList&searchNameOrder=WOUNDDOCS%20M210000077250&aggregateId=forl-m21000007725-f1b44b70-9a19-4f3f-b79d-6a7354791dda
Another update on twitter
$PCLI Rivers Edge 2 subdivision receiving sewer and water infrastructure materials for utility installation. pic.twitter.com/cNqRUrPcSt
— Protocall Technologies ($PCLI) (@OfficialPCLI) February 9, 2022
About to start building houses
$PCLI Rivers Edge 2 subdivision has received all required permits and approvals for construction at January 12, 2022 preconstruction meeting. Construction set to begin approx 2 weeks, weather permitting.
— Protocall Technologies ($PCLI) (@OfficialPCLI) February 7, 2022
Annual report due 3/31 if they want to stay current, 90 days after fiscal year end 12/31
This is a completely different company since Paul acquired the ticker
The Exchange Ratio is subject to adjustment as follows:
If the 10-day VWAP of Planet 13 common shares (the "Planet 13 Shares") on the CSE immediately preceding the second business day prior to the closing of the Transaction (the "Planet 13 Closing Price") is below C$5.50 but above C$4.06, then the Exchange Ratio will be calculated as C$0.4650 divided by the Planet 13 Closing Price;
If the Planet 13 Closing Price is less than or equal to C$4.06, then the Exchange Ratio shall be 0.1145; and
If the Planet 13 Closing Price is greater than or equal to C$5.50, then the Exchange Ratio shall be 0.0845.
https://www.otcmarkets.com/stock/NXGWF/news/Planet-13-to-Acquire-Next-Green-Wave-Holdings-Expanding-Presence-in-California-with-Premium-Indoor-Cultivation-and-an-Ex?id=336690
Link for the class action website. If you bought CannTrust from 6/1/2018 through 9/17/2019, you have until 3/16/2022 to submit a claim
https://canntrustsecuritiessettlement.ca/
The 0.465 cad price only holds if PLTH is between 4.06 and 5.50c. It's at 3.74c now, so NGW would convert to about 0.429c (0.34 usd for NXGWF). I made a table to show the conv prices based on PLTH price
http://stocktwits.com/YM4208/message/422574050
Tax loss selling. I bought 100k shares today for $220
Foreign just means it was originally formed in a different state than Florida, Delaware in this case. The Puerto Rico company is interesting, Otiko's ViaDerma Distribution LLC is also registered in PR.
Dr Otiko has been busy elsewhere. He formed a new Woundscape LLC last month with podiatrist and amputation prevention specialist Dr Bill Releford from https://relefordinstitute.com
Company is registered in Delaware and Florida
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=WOUNDSCAPE%20M210000150390&aggregateId=forl-m21000015039-e44bb26f-eb11-4fb3-80b4-b117c66c175a
ViaDerma is connected to nearly every other active tetracycline "ointment" on the national drug registry. IMO, the new product is either a license deal or competition
I couldn't find a connection either, still searching
New tetracycline hcl 3% ointment published on NIH DailyMed website 12/3. Could be a new licensing deal. Packaging style and inactive ingredients are different than other ViaDerma products
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d22c76c3-ebef-3229-e053-2a95a90a2b32